mezlocillin has been researched along with cefazolin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Drucker, M; Konisberger, H; Leibovici, L; Pitlik, SD; Samra, Z; Wysenbeek, AJ | 1 |
| Gonen, R; Hakim, M; Levitan, Z; Sharf, M | 1 |
| Billings, P; Cooper, M; Leaper, D; Turner, A | 1 |
| Malottke, R; Potel, J | 1 |
2 trial(s) available for mezlocillin and cefazolin
| Article | Year |
|---|---|
Broad spectrum antibiotics as short term prophylaxis for elective abdominal hysterectomy: comparison of mezlocillin, cefazolin and placebo.
Topics: Cefazolin; Cellulitis; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hysterectomy; Mezlocillin; Middle Aged; Postoperative Complications; Premedication; Random Allocation; Surgical Wound Infection; Time Factors; Urinary Tract Infections | 1986 |
Intraoperative microbiological sampling is unhelpful after prophylactic antibiotic.
Topics: Bacteria; Bacterial Infections; Cefazolin; Cefotetan; Clinical Trials as Topic; Gastrointestinal Diseases; Humans; Mezlocillin; Postoperative Complications; Random Allocation; Surgical Wound Infection | 1987 |
6 other study(ies) available for mezlocillin and cefazolin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Patterns of multiple resistance to antibiotics in gram-negative bacteria demonstrated by factor analysis.
Topics: Ampicillin; Cefazolin; Drug Resistance, Microbial; Escherichia coli; Factor Analysis, Statistical; Gram-Negative Bacteria; Humans; Klebsiella; Mezlocillin; Pseudomonas | 1992 |
Antibacterial activity of temocillin.
Topics: Cefazolin; Cefotaxime; Dose-Response Relationship, Drug; Enterobacteriaceae; In Vitro Techniques; Mezlocillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin | 1985 |